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Abstract
Background: There are few studies about predictors of ST elevation myocardial infarction
(STEMI) in young patients. High red cell distribution width (RDW) levels were associated
with adverse outcomes in patients with STEMI. We aimed to investigate the relationship
between RDW and STEMI in young patients.
Methods: This study included 370 patients who presented to our hospital with acute myocardial
infarction (Group 1: 198 young patients, < 45 ages for male, < 55 ages for female, Group 2:
172 elderly patients) and 156 adults with normal coronary angiography as a control group (Group 3:
91 young patients, < 45 ages for male, < 55 ages for female, Group 4: 65 elderly patients).
Results: Compared with Group 3, Group 1 had a significantly higher value of RDW (Group 1
RDW 14.1 ± 1.1%, Group 3 RDW 13.4 ± 0.9, p1 < 0.01). Value of RDW was similar both of
Group 2 and 4 (Group 2 RDW 13.7 ± 1.2, Group 4 RDW 13.5 ± 0.9, p2 = 0.1). After
multivariate analysis, high levels of RDW were independent predictors of STEMI in young
patients (OR: 0.337, p < 0.01) together with gender (OR: 3.725, p < 0.01), history of
hyperlipidemia (OR: 25.172, p < 0.01) and high density lipoprotein cholesterol (OR: 1.088,
p < 0.01).
Conclusions: High levels of RDW were associated with STEMI in young patients. We think
that RDW is a widely available marker with no additional costs, in contrast to other novel
markers of cardiovascular risk. (Cardiol J 2012; 19, 6: 597–602)
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Introduction
Red cell distribution width (RDW) is a labora-
tory measure of the variability in erythrocyte vo-
lume and is a readily available component of the rou-
tine complete blood count. Recent studies have
showed that high RDW levels were associated with
adverse outcomes in patients with ST elevation
myocardial infarction (STEMI) and heart failure [1, 2].
High levels of RDW also associated with increased
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mortality in patients with coronary artery disease
(CAD) and patients undergoing percutaneous coro-
nary intervention [3, 4]. A relation between RDW
and complexity of CAD were shown in a previous
study [5]. In spite of these associations, the mecha-
nisms underlying elevated RDW are unclear in
these patient groups. Inflammation and neurohu-
moral mediators may stimulate changes in red cell
membrane, leading to increased RDW [6].
Investigators showed that only 5% of STEMI
patients were younger than 40 ages [7]. Therefore,
there are few studies about predictors of STEMI in
young patients and no study has investigated the
relationship between RDW and STEMI in this group.
In this study, we aimed to investigate the relation-
ship between RDW and STEMI in young patients.
Methods
Patients
We investigated 370 consecutive patients hos-
pitalized with STEMI patients who admitted with-
in 6 h from symptom onset and underwent primary
percutaneous coronary intervention and 156 adults
with normal coronary angiography as control
groups. Patients were devided into 4 groups: Group 1
included 198 (37%) young patients (< 45 ages for
males, < 55 ages for females), Group 2 — 172 (32%)
elderly patients (> 45 ages for males, > 55 ages for
females) with STEMI, Group 3 — 91 (17%) young
patients and Group 4 — 65 elderly patients with
normal coronary angiography.
Acute myocardial infarction was diagnosed at
least 2 of the following: chest pain longer than
30 min which does not respond to nitrates; in 12-lead
electrocardiography, a new Q wave longer than
40 ms and/or ST segment elevation 0.1 mV on at least
2 extremity derivations or 0.2 mV on precordial
derivation; a 1.5 times, or higher, increase in se-
rum creatine kinase-MB. Patients who had not any
narrowing in coronary arteries were enrolled in the
group 3 and 4 as normal coronary angiography.
Patients with a history of coronary interven-
tion or coronary artery bypass, a history of cardiac
failure, a history of renal disease (or serum creati-
nine level > 1.5 mg/dL), anemia, clinical evidence
of active infection, active cancer, hematological pro-
liferative diseases, active or chronic inflammatory
or autoimmune diseases, pregnancy, recent blood
transfusion and patients with severe arrhythmia
were excluded from the study.
Anemia was defined as hemoglobin levels lower
than 13 g/dL in men and 12 g/dL in women, in accor-
dance with the World Health Organization criteria [8].
The glomerular filtration rate (GFR) was eva-
luated by the simplified Modification of Diet in Re-
nal Disease equation [9]:
GFR = 186 × (Serum Cr)–1.154 × (Age)–0.203
[× 1.210 if African-American] [× 0.742 if female].
Informed consent was obtained from all pa-
tients. The study was approved by our local ethical
committee. All demographic and clinical data were
collected prospectively.
Laboratory analysis
In all cases, blood samples were drawn at ad-
mission before starting any medication and were
collected in tripotassium EDTA tubes. All measure-
ments were performed 30 min after blood collec-
tion by an automatic blood counter (A Sysmex
XE-2100, Symex, Kobe, Japan).
Coronary angiography
Quantitative coronary angiography was per-
formed by two experienced interventional cardiolo-
gists who had no knowledge of the patients’ clinical
information by the Judkins technique via right femo-
ral artery. Coronary arteries were imaged by utili-
zing right and left anterior oblique views with cranial
and caudal positions. Injection of contrast medium
(Iopromide, Ultravist-370; Schering AG, Berlin,
Germany) was carried out by an automatic injector
at a speed of 3–4 L/s for the left coronary artery and
2–3 mL/s for the right coronary artery. Arteriogra-
phies were recorded at a speed of 25 frames/s.
Statistical analysis
All analyses were performed using SPSS V 17.0
for windows (version 17.0, SPSS, Chicago, Illinois,
USA). Quantitative variables were expressed as
mean value ± SD for parametric variables and me-
dian and minimum-maximum levels for non-paramet-
ric variables. Comparison of parametric values be-
tween 2 groups was performed by means of Indepen-
dent-Samples T test. Comparison of non-parametric
values between 2 groups was performed by Mann-
-Whitney U test. Categorical variables were compared
by the c2 test. The Pearson test was used for corre-
lation of parametric variables and the Spearman test
was used test for non-parametric variables (p1: com-
paration between Group 1 and Group 3, p2: compa-
ration between Group 2 and Group 4). Multivariate
logistic regression analysis was performed to assess
the effects of RDW and other variables on STEMI in
young patients. A two-tailed p < 0.05 was consi-
dered significant.
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Results
The baseline characteristics and laboratory
data of the 526 included patients are presented in
Table 1. There was no significant difference in the
presence of diabetes mellitus, hypertension, smok-
ing and levels of hemoglobin, total cholesterol, trig-
lycerides and GFR rate between Group 1 and 3. In
Group 1, age was younger, number of male sex and
levels of RDW were higher than in Group 3. Also in
Group 1, history of hyperlipidemia, presence of family
history of CAD, levels of creatinine and LDL-choles-
terol were higher than in Group 3 and levels of platelet
count, HDL-cholesterol were lower than in Group 3.
In Group 2, age, levels of creatinine and GFR
were higher than in Group 4 and level of total cho-
lesterol was lower than in Group 4. Other parame-
ters were similar in Group 2 and 4.
Compared with 3, Group 1 had a significantly
higher value of RDW (Group 1 RDW 14.1 ± 1.1%,
Group 3 RDW 13.4 ± 0.9, p1 < 0.01). But levels of
RDW were similar in Group 2 and 4 (Group 2 RDW
13.7 ± 1.7, Group 4 RDW 13.5 ± 0.9, p2 = 0.1).
Variables found to be statistically significant in
univariate analysis between Group 1 and 3 were
entered into multivariate logistic regression analy-
sis. After multivariate analysis, high levels of RDW
were independent predictors of STEMI in young
patients (OR: 0.337, 95% CI 0.298–0.558, p < 0.01)
together with gender (OR: 3.725, 95% 1.446–9.597,
p < 0.01), history of hyperlipidemia (OR: 25.172,
4.922–128.743, p < 0.01) and high density lipopro-
tein cholesterol (OR: 1.088, 95% CI 1.045–1.132,
p < 0.01) (Table 2).
Discussion
To our knowledge, this is the first study to
evaluate the relationship between RDW and STEMI
in young patients. Our observations suggest that
elevated levels of RDW are associated with an in-
creased risk of STEMI in young patients.
Non-atherosclerotic CAD risk factors are con-
genital coronary abnormalities, connective tissue
disorders, coronary artery aneurysm or coronary
dissection, myocardial bridging and illicit drug us-
age [10–12]. Vasospasm and hypercoagulapathy also
play a role in the pathophysiology of athero-throm-
bosis in young patients with STEMI [13]. Homozy-
gous FV Leiden, protein C deficiency, antiphospho-
lipid antibody syndrome, antithrombin III deficien-
cy; long-term anticoagulation should be considered
for a patient who has suffered a non-atherosclero-
tic thromboembolic event [14].
Coronary atherosclerosis is the main cause of
STEMI in young patients (80% of cases) [15].
Table 1. Association of atherosclerotic characteristics of patients and red cell distribution width.
Group 1 Group 3 P1 Group 2 Group 4 P2
(n = 198)   (n = 91)   (n = 172) (n = 65)
Age [years] 41 ± 4 43 ± 6 0.01 64 ± 10 59 ± 7 < 0.01
Gender (male) 154 (77%) 42 (46%) < 0.01 107 (62%) 37 (56%) 0.4
Smoking 82 (41%) 35 (38%) 0.5 71 (41%) 26 (40%) 0.8
Diabetes 40 (20%) 12 (13%) 0.1 45 (26%) 12 (23%) 0.2
Hypertension 42 (21%) 14 (15%) 0.2 66 (38%) 21 (32%) 0.4
Hyperlipidemia 44 (22%) 8 (8%) < 0.01 50 (29%) 22 (33%) 0.5
Family history of CAD 66 (33%) 16 (17%) < 0.01 42 (24%) 11 (16%) 0.3
Platelet count (× 106) 238 (117-463) 249 (133-456) 0.04 235 (109-474) 245 (110-436) 0.5
Hemoglobin [mg/dL] 14.5 ± 1.4 14.2 ± 1.5 0.2 14.3 ± 1.2 14.2 ± 1.4 0.5
RDW [%] 14.1 ± 1.1 13.4 ± 0.9 < 0.01 13.7 ± 1.2 13.5 ± 0.9 0.1
BUN [mg/dL] 24 (10–96) 25 (14–54) 0.01 27 (10–92) 28 (19–58) 0.2
Creatinine [mg/dL] 0.89 ± 0.2 0.80 ± 0.1 < 0.01 0.93 ± 0.2 0.82 ± 0.2 < 0.01
Total cholesterol [mg/dL] 185 ± 44 178 ± 39 0.2 178 ± 36 164 ± 40 < 0.01
LDL-C [mg/dL] 125 ± 39 114 ± 36 0.04 119 ± 32 119 ± 34 0.9
HDL-C [mg/dL] 38 ± 8 47 ± 12 < 0.01 38 ± 8 43 ± 13 0.07
Triglycerides [mg/dL] 135 (40–467) 132 (34–357) 0.8 130 (32–460) 125 (50–424) 0.8
GFR [mL/min/1.73 m2] 100 ± 28 98 ± 20 0.9 82 ± 26 93 ± 18 < 0.01
CAD — coronary artery disease; RDW — red cell distribution width; BUN — blood urea nitrogen; LDL-C — low density lipoprotein cholesterol;
HDL-C — high density lipoprotein cholesterol; GFR — glomerular filtration rate; p1 — comparation between Group 1 and Group 3; p2 — comparation
between Group 2 and Group 4
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Atherosclerotic process begins at birth and significant
lesions in coronary arteries can be detected as ear-
ly as age 25 or 30 years. In a postmortem study
that included 760 young adults (average age of
30–34 years), 20% of males and 8% of females were
found to have atherosclerotic CAD [16]. All well-
-known classic risk factors for atherosclerosis are
acceptable for young patients with STEMI. In addi-
tion to the classical risk factors there are new pre-
dictors for atherosclerosis in young patients such
as lipoprotein a, fibrinogen and uric acid [17].
RDW is a marker of the variability in erythro-
cyte volume and is a routinely available component
of the complete blood count. Elevated RDW reflects
heterogeneity of cell sizes in the peripheral blood
smear [18]. Elevated RDW levels can be seen in
conditions of ineffective red cell production (such
as iron deficiency, B12 or folat deficiency and he-
moglobinopathies), increased red cell destruction
(such as hemolysis) and with blood transfusion [19].
The underlying mechanism by which high le-
vels of RDW are associated with STEMI is unclear.
Inflammation have an important role in atheroscle-
rotic process [20]. Inflammatory cytokines which
are activated in STEMI have been found to suppress
the erythrocyte maturation, so juvenile erythro-
cytes enter into circulation [21]. Also elevated lev-
els of neurohumoral mediators stimulate erythro-
poiesis, for example, angiotensin II may affect the
erythroid progenitor cells with a direct stimulation
[6]. In addition, levels of erythropoietin increases
independent of hemoglobin levels and adrenergic
activation may act bone marrow response in patients
with STEMI [22]. There is a substantial genetic
contribution to red cell size in general population
[23]. The variability in circulation red cell sizes may
increase with these mechanisms. The investigators
showed a relationship between generalized inflam-
mation and elevated levels of RDW and demonstrat-
ed an association of RDW with high sensitive C-re-
active protein and erythrocyte sedimentation rate
which are indicators of inflammation [24].
Several studies evaluated a relation between
increased RDW and morbidity and mortality of
CAD. Investigators showed that an increased RDW
was independently associated with in hospital and
long-term all-cause mortality and coronary events
in STEMI, non-ST elevation MI and unselected
population of male patients referred for coronary
angiography [2, 25, 26]. Also in other studies a high
admission RDW was independently associated with
worse reperfusion and increased risk in-hospital and
long-term cardiovascular mortality in patients with
STEMI undergoing primary percutaneous interven-
tion [27]. In a study of 7556 adult participants (de-
vided into 3 categories according to their 10-year
Framingham risk of hard CAD events; < 10%, 10–
–20%, > 20%) were found that a higher RDW might
be a powerful independent predictor of future cor-
onary heart disease risk [28]. Isik et al. [5] demon-
strated that RDW was independently associated
with the presence of CAD and coronary complexi-
ty of CAD as assessed by the SYNTAX score.
In our study, we found that high levels of RDW
were associated with STEMI in young patients. As
we mentioned in the result section, levels of RDW
were similar in elderly patients with STEMI and
normal coronary angiography. Levels of RDW were
Table 2. Multivariate analysis of determinants of myocardial infarction in young patients.
95% CI for Exp(B)
B SE Wald df Sig. Exp(B) Lower Upper
RDW –1.089 0.221 24.206 1 0.000 0.337 0.218 0.519
Gender 1.315  0.483 7.415 1 0.006 3.725 1.446 9.597
History of HPL 3.226 0.833 15.006 1 0.000 25.172 4.922 128.743
Family history of CAD 0.762 0.462 2.725 1 0.099 2.143 0.867 5.298
Platelets 0.003 0.003 1.290 1 0.256 1.003 0.998 1.008
BUN 0.014 0.020 0.519 1 0.471 1.014 0.976 1.055
Creatinine –1.473 0.998 2.181 1 0.140  .229 0.032 1.619
LDL-C 0.000 0.005 0.025 1 0.873  .999 0.990 1.009
HDL-C 0.084 0.021 16.775 1 0.000 1.088 1.045 1.132
Age 0.024 0.041 0.338 1 0.561 1.024 0.945 1.109
Constant 5.669  3.322 2.911 1 0.088 289.758
CI — confidence interval; SE — standard error; df — degrees of freedom; RDW — red cell distribution width; HPL — hyperlipidemia; CAD — coronary
artery disease; BUN — blood urea nitrogen; LDL-C — low density lipoprotein cholesterol; HDL-C — high density lipoprotein cholesterol
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higher only in young patients with STEMI in our
study. It is well known that RDW is higher in eld-
erly patients, also in patients with and without CAD.
This situation may explain the similar value of RDW
in both elderly groups.
The underlying mechanisms between RDW
and cardiovascular morbidity and mortality have not
yet been clearly demonstrated. Some hypotheses
were suggested for this association. Atherosclerotic
process was related with inflammatory reactions
and elevated levels of RDW were associated with
inflammation markers such as high sensitive C-re-
active protein and erythrocyte sedimentation rate.
As we mentioned above related inflammatory cy-
tokines suppress the erythrocyte maturation, so
juvenile erythrocytes enter into circulation. Also
elevated levels of neurohumoral mediators and ad-
renergic activation stimulate erythropoiesis. In ad-
dition, there is a substantial genetic contribution to
red cell size in general population [23]. The varia-
bility in circulation red cell sizes may increase with
these mechanisms.
Only hemoglobin levels were measured in this
study and other factors including, levels of iron,
vitamin B12, folate and mean corpuscular volume
were not measured. But also, we did not implicate
the patients with anemia to our study. We believe
that this makes it highly unlikely that the predic-
tive value of RDW was related to iron deficiency.
Furthermore, the incidence of clinically significant
vitamin B12 and folate deficiency is low in a mo-
dern population. In a study of 15,852 adult partici-
pants were found that RDW was an independent
predictor of mortality and the investigators conclud-
ed that the relationship between RDW and morta-
lity was not confounded by anemia-related deficien-
cies such as vitamin B12, folate and iron [29].
History of hyperlipidemia was found to be more
common in group 1 than group 3. Based on this re-
sult, the more common presence of history of hy-
perlipidemia in young patients indicates the impor-
tance of familial hypercholesterolemia in this group,
as expected.
HDL levels were lower in Group 1 than Group
3. Several studies indicate significantly higher le-
vels of triglicerydes and total cholesterol and lower
concentration of HDL-cholesterol in young patients
with CAD, compared with elderly patients [30]. In
our study, LDL-cholesterol were higher, HDL-cho-
lesterol was lower in young patients with STEMI
than normal group. But we did not find any signifi-
cant difference between elderly groups. We did not
have any information about patient’s medication.
This result may related with usage of antihyperli-
pidemic drugs by elderly patients.
Limitations of the study
There are several limitations in our study. We
did not evaluate other novel risk factors for STEMI
in young patients such as fibrinogen, CD 40 ligand,
FV Leiden, protein C and antithrombin III and could
not evaluate the medical history of patients. Only
hemoglobin levels were measured in this study and
other factors including, levels of iron, ferritin, vita-
min B12 and folate were not measured. We did not
evaluate etiology of STEMI in our study groups
(vasospasm, congenital coronary abnormalities and
others). So we could not compare levels of RDW
according to atherosclerotic origin and nonathero-
sclerotic origin.
Conclusions
We found that high levels of RDW were asso-
ciated with STEMI in young patients. Also we think
that RDW is a widely available marker with no ad-
ditional costs, in contrast to other novel markers
of cardiovascular risk.
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